1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 128 results for "Cellular Therapy (CT)".

$Thumbnail for Impact of Loss of B-Cell Aplasia on Clinical Outcomes Following Talicabtagene Autoleucel in Patients With Relapsed/Refractory B-Cell Malignancies: A Single-Center Real-World Experience$

CT - 1231

Impact of Loss of B-Cell Aplasia on Clinical Outcomes Following Talicabtagene Autoleucel in Patients With Relapsed/Refractory B-Cell Malignancies: A Single-Center Real-World Experience

Sahitya Rao

Poster Presenter: Sahitya Rao

CT - 126

Does CAR-T Therapy Overcome TP53-Driven Resistance in Lymphoma? A Systematic Review of Clinical Outcomes

Mostafa F Mohammed Saleh

Poster Presenter: Mostafa F Mohammed Saleh

SOHO 2026 Annual Meeting

Topics

Impact of Loss of B-Cell Aplasia on Clinical Outcomes Following Talicabtagene Autoleucel in Patients With Relapsed/Refractory B-Cell Malignancies: A Single-Center Real-World Experience

Does CAR-T Therapy Overcome TP53-Driven Resistance in Lymphoma? A Systematic Review of Clinical Outcomes

Therapy-Related Myeloid Neoplasms Following CAR-T Therapy: Emerging Patterns, Risk Factors, and Clinical Challenges

Immune Effector Cell (IEC)-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome (IEC-HS) in Patients With Hematologic Malignancies: A Systematic Review and Meta-Analysis

State-Resolved Regulatory Profiling Identifies Product-Specific Transcription Factor and Pathway Activity in Axi-Cel and Tisa-Cel Infusion Products

Obstructive Sleep Apnea and Outcomes After CAR-T Therapy in Diffuse Large B-Cell Lymphoma: A Real-World TriNetX Study

Cardiovascular and Survival Outcomes Among Adults With Hematologic Malignancies Receiving Anthracyclines With vs Without Dexrazoxane: A Real-World Propensity-Matched Analysis

Postransplant Cyclophosphamide Is Associated With Improved Long-Term Survival Following Second Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World Propensity Score-Matched Analysis

Real-World Incidence of Severe Inpatient Toxicity During Bispecific T-Cell Engager Therapy Initiation: A 2023 National Inpatient Sample Analysis